放射肿瘤诊所中脑转移瘤患者的生活质量与认知功能评估及干预
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.
作者信息
Matsui Jennifer K, Perlow Haley K, Baiyee Cyril, Ritter Alex R, Mishra Mark V, Bovi Joseph A, Gondi Vinai, Brown Paul D, Loughan Ashlee R, Leeper Heather E, Dawson Erica, Palmer Joshua D
机构信息
College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
出版信息
Cancers (Basel). 2022 Sep 1;14(17):4301. doi: 10.3390/cancers14174301.
Abstract
Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.
摘要
脑转移瘤（BMs）在癌症发病率和死亡率中所占比例过高。从历史上看，研究主要集中在改善生存结果，最近的放射肿瘤学临床试验纳入了健康相关生活质量（HRQOL）和认知评估。目前，我们在放射肿瘤学诊所配备了一系列评估手段，但对于如何将这些评估纳入现代临床实践，尚无共识。在此，我们介绍针对BM患者的经过验证的评估方法、对未来临床研究的当前建议，以及改善BM患者HRQOL和认知结果的治疗进展。
相似文献
1
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic.
Cancers (Basel). 2022 Sep 1;14(17):4301. doi: 10.3390/cancers14174301.
2
Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
J Neurosurg. 2018 Jul;129(1):71-83. doi: 10.3171/2017.2.JNS161659. Epub 2017 Aug 18.
3
Narrative review of neurocognitive and quality of life tools used in brain metastases trials.
Ann Palliat Med. 2021 Jan;10(1):923-935. doi: 10.21037/apm-20-1036. Epub 2020 Dec 31.
4
Health related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review.
J Neurooncol. 2022 Sep;159(2):319-331. doi: 10.1007/s11060-022-04067-8. Epub 2022 Jul 4.
5
Cognitive Functioning and Health-Related Quality of Life of Long-Term Survivors With Brain Metastases Up to 21 Months After Gamma Knife Radiosurgery.
Neurosurgery. 2021 Apr 15;88(5):E396-E405. doi: 10.1093/neuros/nyaa586.
6
The Cognitive Effects of Radiotherapy for Brain Metastases.
Front Oncol. 2022 Jun 30;12:893264. doi: 10.3389/fonc.2022.893264. eCollection 2022.
7
Strategies to Preserve Cognition in Patients With Brain Metastases: A Review.
Front Oncol. 2018 Oct 9;8:415. doi: 10.3389/fonc.2018.00415. eCollection 2018.
8
Quality of life is maintained using Gamma Knife radiosurgery: a prospective study of a brain metastases patient cohort.
J Neurosurg. 2017 Mar;126(3):708-725. doi: 10.3171/2015.10.JNS15801. Epub 2016 Apr 8.
9
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy Oncology Group trial BR-0018.
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1346-52. doi: 10.1016/j.ijrobp.2003.09.023.
10
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology.
J Neurooncol. 2021 Apr;152(2):395-404. doi: 10.1007/s11060-021-03714-w. Epub 2021 Feb 23.
引用本文的文献
1
Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases.
Transl Lung Cancer Res. 2024 Dec 31;13(12):3289-3302. doi: 10.21037/tlcr-24-481. Epub 2024 Dec 27.
2
The effects of immune checkpoint inhibitors vs. chemotherapy combined with brain radiotherapy in non-small cell lung cancer patients with brain metastases.
BMC Cancer. 2024 Oct 31;24(1):1343. doi: 10.1186/s12885-024-13110-y.
3
Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma.
Neuro Oncol. 2024 Mar 4;26(12 Suppl 2):S46-S55. doi: 10.1093/neuonc/noad260.
4
Radiotherapy in Preclinical Models of Brain Metastases: A Review and Recommendations for Future Studies.
Int J Biol Sci. 2024 Jan 1;20(2):765-783. doi: 10.7150/ijbs.91295. eCollection 2024.
5
Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis.
J Transl Med. 2023 Apr 5;21(1):244. doi: 10.1186/s12967-023-04089-4.
6
Remote assessment of cognition and quality of life following radiotherapy for nasopharyngeal carcinoma: deep-learning-based predictive models and MRI correlates.
J Cancer Surviv. 2024 Aug;18(4):1297-1308. doi: 10.1007/s11764-023-01371-8. Epub 2023 Apr 3.
本文引用的文献
1
Preservation of neurocognitive function in the treatment of brain metastases.
Neurooncol Adv. 2021 Nov 27;3(Suppl 5):v96-v107. doi: 10.1093/noajnl/vdab122. eCollection 2021 Nov.
2
Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study.
J Clin Oncol. 2021 Oct 1;39(28):3118-3127. doi: 10.1200/JCO.21.00639. Epub 2021 Aug 11.
3
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
J Thorac Oncol. 2021 May;16(5):840-849. doi: 10.1016/j.jtho.2020.12.024. Epub 2021 Feb 2.
4
Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3-arm randomized trial.
Cancer. 2020 Dec 15;126(24):5328-5336. doi: 10.1002/cncr.33186. Epub 2020 Sep 30.
5
Hippocampal avoidance whole-brain radiotherapy without memantine in preserving neurocognitive function for brain metastases: a phase II blinded randomized trial.
Neuro Oncol. 2021 Mar 25;23(3):478-486. doi: 10.1093/neuonc/noaa193.
6
Quality-of-life trajectories after stereotactic radiosurgery for brain metastases.
J Neurosurg. 2020 Jul 10;134(6):1791-1799. doi: 10.3171/2020.4.JNS20788. Print 2021 Jun 1.
7
Laser Interstitial Thermal Therapy in the treatment of brain metastases and radiation necrosis.
Cancer Lett. 2020 Oct 1;489:9-18. doi: 10.1016/j.canlet.2020.05.014. Epub 2020 Jun 3.
8
Sensitivity of the Montreal Cognitive Assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma.
J Neurooncol. 2020 Jun;148(2):335-342. doi: 10.1007/s11060-020-03524-6. Epub 2020 May 15.
9
Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2020 Mar 2;3(3):e201617. doi: 10.1001/jamanetworkopen.2020.1617.
10
Current approaches to the management of brain metastases.
Nat Rev Clin Oncol. 2020 May;17(5):279-299. doi: 10.1038/s41571-019-0320-3. Epub 2020 Feb 20.
Zotero 插件